Major thrombocytopenia after balloon‐expandable transcatheter aortic valve replacement: Prognostic implications and comparison to surgical aortic valve replacement
Conclusions: Post‐TAVR thrombocytopenia is a common phenomenon and its magnitude appears similar to that seen after SAVR. It is most often transient, not associated with adverse sequelae and, unless persistent, should be managed in an expectant fashion. © 2014 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - Category: Cardiovascular & Thoracic Surgery Authors: Hasan Jilaihawi, Niraj Doctor, Tarun Chakravarty, Mohammad Kashif, James Mirocha, Wen Cheng, Michael Lill, Mamoo Nakamura, Mitch Gheorghiu, Raj Makkar Tags: Original Studie Source Type: research
More News: Bleeding | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Heart | Heart Valve Surgery | Stroke | Thrombocytopenia | Urology & Nephrology